The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy
Tài liệu tham khảo
2018
Atun, 2015, Expanding global access to radiotherapy, Lancet Oncol, 16, 1153, 10.1016/S1470-2045(15)00222-3
Hamilton, 2017, Strategic planning in an academic radiation medicine program, Curr Oncol, 24, e518, 10.3747/co.24.3725
2018
2018
Ontario, 2018
Levinson, 2007, Strategic planning in a complex academic environment: lessons from one academic health center, Acad Med, 82, 806, 10.1097/ACM.0b013e3180d08d14
Becker, 2006, Strategic planning for departmental divisions in an academic health care center, Am J Med, 119, 357, 10.1016/j.amjmed.2006.01.001
Schafer, 2005, Crafting an effective strategic plan for a department of medicine, Am J Med, 118, 315, 10.1016/j.amjmed.2005.01.002
Weitekamp, 1996, Strategic planning for academic health centers, Am J Med, 101, 309, 10.1016/S0002-9343(96)00171-4
2017
Van de Voorde, 2017
Moller, 2003, A prospective survey of radiotherapy practice 2001 in Sweden, Acta Oncol, 42, 387, 10.1080/02841860310011131
Slotman, 2013, Planning of radiotherapy capacity and productivity, Radiother Oncol, 106, 266, 10.1016/j.radonc.2013.02.006
2014
Mackillop, 2015, A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario, Int J Radiat Oncol Biol Phys, 91, 1099, 10.1016/j.ijrobp.2014.11.026
Barton, 2014, Patterns of retreatment by radiotherapy, Clin Ooncol, 26, 611, 10.1016/j.clon.2014.03.008
Khor, 2013, Patterns of retreatment with radiotherapy in a large academic centre, J Med Imaging Radiat Oncol, 57, 610, 10.1111/1754-9485.12066
2013
Mackillop, 1994, Waiting for radiotherapy in Ontario, Int J Radiat Oncol Biol Phys, 30, 221, 10.1016/0360-3016(94)90538-X
Smith, 1995, Efficiency considerations in the expansion of radiation therapy services, Int J Radiat Oncol Biol Phys, 31, 379, 10.1016/0360-3016(94)00473-X
Palma, 2019, Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial, Lancet, 393, 2051, 10.1016/S0140-6736(18)32487-5
Videtic, 2017, Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive summary of an ASTRO evidence-based guideline, Pract Radiat Oncol, 7, 295, 10.1016/j.prro.2017.04.014
Correa, 2019, The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: A systematic review and meta-analysis, Eur Urol Focus, 5, 958, 10.1016/j.euf.2019.06.002
Kishan, 2019, Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2018.8006
Borras, 2015, The need for radiotherapy in Europe in 2020: Not only data but also a cancer plan, Acta Oncol, 54, 1268, 10.3109/0284186X.2015.1062139
Lievens, 2018, The HERO project: Inspire awareness, strengthen radiotherapy, deliver equitable access, J Glob Oncol, 4
Battista, 2012, Medical physics staffing for radiation oncology: A decade of experience in Ontario, Canada, J Appl Clin Med Phys, 13, 3704
Smoke, 2015, Staffing model for radiation therapists in Ontario, J Med Imaging Radiat Sci, 46, 388, 10.1016/j.jmir.2015.08.004
Yap, 2016, Global access to radiotherapy services: Have we made progress during the past decade?, J Glob Oncol, 2, 207, 10.1200/JGO.2015.001545